HNRNPC and liver cancer: Survival analysis revealed robust associations between HNRNPC expression levels and disease-specific survival (DSS), overall survival (OS), progression-free survival (PFS), and disease-free survival (DFS) in patients with liver cancer (p = 3.2e-4, p = 6.5e-3, p = 1.1e-3, and p = 0.02, respectively).